CTI BioPharma ctibiopharma.com


CTI BioPharma is a biopharmaceutical company whose mission is to acquire, develop and bring to market less toxic, more effective therapies to treat and cure cancer. The company's therapeutic focus is on novel targeted therapies covering a spectrum of blood-related cancers. CTI sees patients as people, looking at potential therapies from the patient's perspective to address both the clinical need and the impact treatment can have on a patient's life. The company prioritizes the patient experience...Show all

CTI BioPharma is a biopharmaceutical company whose mission is to acquire, develop and bring to market less toxic, more effective therapies to treat and cure cancer. The company's therapeutic focus is on novel targeted therapies covering a spectrum of...Show all

Company (IPO / Went public)

Phone: 206-282-7100

Fax:

3101 Western Avenue
Suite 800
 Seattle, 98121
 Washington, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
CTI BioPharma $30M Mar 21, 1997

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related CTI BioPharma Jobs

jobs by Indeed job search
There is no Board of Directors data available for this company. Please select another tab.
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)
Oxygen linked pyrimidine derivatives Jan 05, 2017 Dec 31, 2019 Patent
11-2(2-pyrrolidin-1-yl-ethoxy)-14,19-dioxa-5,7,26-triaza-tetracyclo[19.3.1.1(2,6).1(8,12)]heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene citrate salt Feb 13, 2015 Apr 18, 2017 Patent
Oxygen linked pyrimidine derivatives Feb 20, 2013 Feb 21, 2017 Patent
Injectable pharmaceutical compositions of an anthracenedione derivative with anti-tumoral activity Dec 10, 2010 Dec 15, 2015 Patent
Peptide nucleic acid derivatives with good cell penetration and strong affinity for nucleic acid Dec 19, 2013 Nov 25, 2014 Patent
See all 10 patents